share_log

Invivyd | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Invivyd | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Invivyd | S-8：员工福利计划证券登记
美股sec公告 ·  05/09 16:50
Moomoo AI 已提取核心信息
On May 9, 2024, Invivyd, Inc., a biotechnology company based in Waltham, Massachusetts, filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC). The filing is intended to register an additional 3,304,820 shares of common stock under the company's 2021 Equity Incentive Plan. This move follows the provisions of the 2021 Plan, which allows for an automatic increase in the number of shares reserved for issuance each year. The newly registered shares are set to support the company's equity incentive efforts, aimed at attracting and retaining talent. Invivyd, Inc. has incorporated by reference its previous filings, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and other relevant documents. The company, identified as a non-accelerated filer, a smaller reporting company, and an emerging growth company, has also included various exhibits and legal opinions in the registration statement.
On May 9, 2024, Invivyd, Inc., a biotechnology company based in Waltham, Massachusetts, filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC). The filing is intended to register an additional 3,304,820 shares of common stock under the company's 2021 Equity Incentive Plan. This move follows the provisions of the 2021 Plan, which allows for an automatic increase in the number of shares reserved for issuance each year. The newly registered shares are set to support the company's equity incentive efforts, aimed at attracting and retaining talent. Invivyd, Inc. has incorporated by reference its previous filings, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and other relevant documents. The company, identified as a non-accelerated filer, a smaller reporting company, and an emerging growth company, has also included various exhibits and legal opinions in the registration statement.
2024年5月9日，总部位于马萨诸塞州沃尔瑟姆的生物技术公司Invivyd, Inc. 向美国证券交易委员会（SEC）提交了S-8表格的注册声明。该文件旨在根据公司的2021年股权激励计划再注册3,304,820股普通股。此举遵循了2021年计划的规定，该计划允许每年自动增加预留发行的股票数量。新注册的股票将支持公司的股权激励工作，旨在吸引和留住人才。Invivyd, Inc.以引用方式纳入了其先前提交的文件，包括截至2023年12月31日财年的10-K表年度报告和其他相关文件。该公司被认定为非加速申报人、小型申报公司和新兴成长型公司，还在注册声明中纳入了各种证物和法律意见。
2024年5月9日，总部位于马萨诸塞州沃尔瑟姆的生物技术公司Invivyd, Inc. 向美国证券交易委员会（SEC）提交了S-8表格的注册声明。该文件旨在根据公司的2021年股权激励计划再注册3,304,820股普通股。此举遵循了2021年计划的规定，该计划允许每年自动增加预留发行的股票数量。新注册的股票将支持公司的股权激励工作，旨在吸引和留住人才。Invivyd, Inc.以引用方式纳入了其先前提交的文件，包括截至2023年12月31日财年的10-K表年度报告和其他相关文件。该公司被认定为非加速申报人、小型申报公司和新兴成长型公司，还在注册声明中纳入了各种证物和法律意见。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息